Article
Platform comparison for evaluation of ALK protein immunohistochemical expression, genomic copy number and hotspot mutation status in neuroblastomas.
PloS one - 1 Jan 2014
Yan Benedict, Kuick Chik Hong, Lim Malcolm, Venkataraman Kavita, Tennakoon Chandana, Loh Eva, Lian Derrick, Leong May Ying, Lakshmanan Manikandan, Tergaonkar Vinay, Sung Wing-Kin, Soh Shui Yen, Chang Kenneth T E
Abstract excerpt
ALK is an established causative oncogenic driver in neuroblastoma, and is likely to emerge as a routine biomarker in neuroblastoma diagnostics. At present, the optimal strategy for clinical diagnostic evaluation of ALK protein, genomic and hotspot mutation status is not well-studied. We evaluated ALK immunohistochemical (IHC) protein expression using three different antibodies (ALK1, 5A4 and D5F3 clones), ALK...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
